secwatch.observer — SEC 8-K summary
======================================

Issuer:     MiNK Therapeutics, Inc. (INKT)
CIK:        0001840229
Form:       8-K
Filed at:   2024-08-30T23:59:59+00:00
Accession:  0000950170-24-102321
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

MiNK Therapeutics receives Nasdaq delisting notice for failing to meet $1.00 bid price rule
--------------------------------------------------------------------------------

- Nasdaq notified MiNK on Aug 27, 2024 that it failed to regain compliance with the $1.00 minimum bid price within the 180-day grace period ending Aug 26, 2024.
- Common stock (INKT) is now subject to potential delisting from Nasdaq.
- MiNK intends to request a hearing before the Nasdaq Hearings Panel, which will stay any delisting action pending the process.
- No assurance that the Panel will allow continued listing or that compliance can be demonstrated within any extension granted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840229/000095017024102321/0000950170-24-102321-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840229/000095017024102321/inkt-20240827.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-102321

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer